Human Papillomavirus in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era-Reference-Cited by-同舟云学术

Human Papillomavirus in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era

Published:2015-02-03 Issue:1 Volume:12 Page:6-15
ISSN:1548-3568
Container-title:Current HIV/AIDS Reports
language:en
Short-container-title:Curr HIV/AIDS Rep

Author:

Brickman Cristina,Palefsky Joel M.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Link

http://link.springer.com/content/pdf/10.1007/s11904-014-0254-4.pdf

Reference97 articles.

1. Stanley M, Lowy DR, Frazer I. Chapter 12: prophylactic HPV vaccines: underlying mechanisms. Vaccine. 2006;24 Suppl 3:S3/106–13.

2. Schiffman M et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907.

3. Centers for Disease, C. and Prevention. Human papillomavirus-associated cancers—United States, 2004–2008. MMWR Morb Mortal Wkly Rep. 2012;61:258–61.

4. Chaturvedi AK et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101(16):1120–30.

5. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500–10.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer;Viruses;2024-09-05

2. Prevalence and correlates of Human Papillomavirus infection in females from Southern Province, Zambia: A cross-sectional study;PLOS ONE;2024-08-01

3. Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross sectional study;BMC Public Health;2024-07-09

4. Intraepithelial CD15 infiltration identifies high-grade anal dysplasia in people with HIV;JCI Insight;2024-06-20

5. Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020);Human Vaccines & Immunotherapeutics;2024-04